Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling
Makoto Sumitomo, … , Beatrice Knudsen, David M. Nanus
Makoto Sumitomo, … , Beatrice Knudsen, David M. Nanus
Published December 1, 2000
Citation Information: J Clin Invest. 2000;106(11):1399-1407. https://doi.org/10.1172/JCI10536.
View: Text | PDF
Article Article has an altmetric score of 3

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling

  • Text
  • PDF
Abstract

Neutral endopeptidase 24.11 (NEP, CD10) is a cell-surface enzyme expressed by prostatic epithelial cells that cleaves and inactivates neuropeptides implicated in the growth of androgen-independent prostate cancer (PC). NEP substrates such as bombesin and endothelin-1 induce cell migration. We investigated the mechanisms of NEP regulation of cell migration in PC cells, including regulation of phosphorylation on tyrosine of focal adhesion kinase (FAK). Western analyses and cell migration assays revealed an inverse correlation between NEP expression and the levels of FAK phosphorylation and cell migration in PC cell lines. Constitutively expressed NEP, recombinant NEP, and induced NEP expression using a tetracycline-repressive expression system inhibited bombesin- and endothelin-1–stimulated FAK phosphorylation and cell migration. This results from NEP-induced inhibition of neuropeptide-stimulated association of FAK with cSrc protein. Expression of a mutated catalytically inactive NEP protein also resulted in partial inhibition of FAK phosphorylation and cell migration. Coimmunoprecipitation experiments show that NEP associates with tyrosine-phosphorylated Lyn kinase, which then binds the p85 subunit of phosphatidylinositol 3-kinase (PI3-K) resulting in an NEP-Lyn-PI3-K protein complex. This complex competitively blocks FAK-PI3-K interaction, suggesting that NEP protein inhibits cell migration via a protein-protein interaction independent of its catalytic function. These experiments demonstrate that NEP can inhibit FAK phosphorylation on tyrosine and PC cell migration through multiple pathways and suggest that cell migration which contributes to invasion and metastases in PC cells can be regulated by NEP.

Authors

Makoto Sumitomo, Ruoqian Shen, Marc Walburg, Jie Dai, Yiping Geng, Daniel Navarro, Guy Boileau, Christos N. Papandreou, Filippo G. Giancotti, Beatrice Knudsen, David M. Nanus

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 2007 2005 2004 2002 Total
Citations: 1 1 2 1 1 1 1 3 2 2 3 5 3 5 2 4 1 1 2 41
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (41)

Title and authors Publication Year
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Onyiba CI, Kumar NK, Scarlett CJ, Weidenhofer J
Cells 2025
Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives.
Costagliola A, Lombardi R, Liguori G, Morrione A, Giordano A
Cancer genomics & proteomics 2023
Ovarian cancer G protein-coupled receptor 1 inhibits A549 cells migration through casein kinase 2α intronless gene and neutral endopeptidase.
Sharma AL, Meitei PM, Machathoibi TC, Singh NT, Singh TR, Singh LS
BMC Cancer 2022
Prognostic Neurotransmitter Receptors Genes Are Associated with Immune Response, Inflammation and Cancer Hallmarks in Brain Tumors
Belotti Y, Tolomeo S, Yu R, Lim WT, Lim CT
Cancers 2022
Distinct roles for the RNA-binding protein Staufen1 in prostate cancer
KA Marcellus, TE Parks, S Almasi, BJ Jasmin
BMC Cancer 2021
Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells
CY Cheng, Z Zhou, M Stone, B Lu, A Flesken-Nikitin, DM Nanus, AY Nikitin
Oncogenesis 2020
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
A Couvineau, S Dayot, P Nicole, V Gratio, V Rebours, A Couvelard, T Voisin
Frontiers in Endocrinology 2018
Eviction from the Sanctuary: Development of Targeted Therapy Against Cell Adhesion Molecules in Acute Lymphoblastic Leukemia
SP Barwe, A Quagliano, A Gopalakrishnapillai
Seminars in Oncology 2017
Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development
M Mizerska-Kowalska, A Bojarska-Junak, J Jakubowicz-Gil, M Kandefer-Szerszeń
Tumor Biology 2016
Epigenetic suppression of neprilysin regulates breast cancer invasion
HM Stephen, RJ Khoury, PR Majmudar, T Blaylock, K Hawkins, MS Salama, MD Scott, B Cosminsky, NK Utreja, J Britt, RE Conway
Oncogenesis 2016
Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis
D Mishra, S Singh, G Narayan
Molecular Biology International 2016
Neural Regulation of Hematopoiesis, Inflammation, and Cancer
M Hanoun, M Maryanovich, A Arnal-Estapé, PS Frenette
Neuron 2015
Extracellular Molecules Involved in Cancer Cell Invasion
T Stivarou, E Patsavoudi
Cancers 2015
Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?
M Mizerska-Dudka, M Kandefer-Szerszeń
Archivum Immunologiae et Therapiae Experimentalis 2014
Regulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer
S Saini, S Majid, V Shahryari, ZL Tabatabai, S Arora, S Yamamura, Y Tanaka, R Dahiya, G Deng
Molecular cancer therapeutics 2014
Neprilysin deficiency protects against fat-induced insulin secretory dysfunction by maintaining calcium influx
S Zraika, DS Koh, BM Barrow, B Lu, SE Kahn, S Andrikopoulos
Diabetes 2013
RTK/ERK pathway under natural selection associated with prostate cancer
Y Chen, X Xin, J Li, J Xu, X Yu, T Li, Z Mo, Y Hu
PloS one 2013
Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer
C Wang, LP Schwab, M Fan, TN Seagroves, JK Buolamwini
Cancer prevention research (Philadelphia, Pa.) 2013
Tumor-Initiating Label-Retaining Cancer Cells in Human Gastrointestinal Cancers Undergo Asymmetric Cell Division
HW Xin, DM Hari, JE Mullinax, CM Ambe, T Koizumi, S Ray, AJ Anderson, GW Wiegand, SH Garfield, SS Thorgeirsson, I Avital
Stem Cells 2012
The Src kinase Yes is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters, but not pancreatic growth factors, which stimulate its association with numerous other signaling molecules
V Sancho, B Nuche-Berenguer, RT Jensen
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2012
Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery
J Koffler, D Holzinger, GA Sanhueza, C Flechtenmacher, K Zaoui, B Lahrmann, N Grabe, PK Plinkert, J Hess
European Archives of Oto-Rhino-Laryngology 2012
Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer
K Iida, R Zheng, R Shen, DM Nanus
International journal of oncology 2012
Functions of the Lyn tyrosine kinase in health and disease
E Ingley
Cell Communication and Signaling 2012
Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
A Patrikidou, PJ Vlachostergios, IA Voutsadakis, E Hatzidaki, RM Valeri, C Destouni, E Apostolou, D Daliani, CN Papandreou
Cancer Cell International 2011
CD10 Expression in Epithelial and Stromal Cells of Non-small Cell Lung Carcinoma (NSCLC): A Clinic and Pathologic Correlation
D Gürel, A Kargı, I Karaman, A Önen, M Ünlü
Pathology & Oncology Research 2011
Toward an Integrative Analysis of the Tumor Microenvironment in Ovarian Epithelial Carcinoma
RN Serio
Cancer Microenvironment 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
CD10 expression in urothelial carcinoma of the bladder
B Bahadir, K Behzatoglu, S Bektas, ER Bozkurt, SO Ozdamar
Diagnostic Pathology 2009
Rational redesign of neutral endopeptidase binding to merlin and moesin proteins
MY Niv, K Iida, R Zheng, A Horiguchi, R Shen, DM Nanus
Protein science : a publication of the Protein Society 2009
FYN is overexpressed in human prostate cancer
EM Posadas, H Al-Ahmadie, VL Robinson, R Jagadeeswaran, K Otto, KE Kasza, M Tretiakov, J Siddiqui, KJ Pienta, WM Stadler, C Rinker-Schaeffer, R Salgia
BJU International 2009
Neutral endopeptidase is a myristoylated protein
R Zheng, A Horiguchi, K Iida, J Lee, R Shen, OB Goodman, DM Nanus
Molecular and Cellular Biochemistry 2009
Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability
S Gunia, K Albrecht, S Koch, T Herrmann, T Ecke, V Loy, J Linke, M Siegsmund, M May
World Journal of Urology 2008
Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells
YM Fu, ZX Yu, H Lin, X Fu, GG Meadows
Journal of Cellular Physiology 2008
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling
S Thomas, M Chiriva-Internati, GV Shah
Clinical & Experimental Metastasis 2007
Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells
J Zhu, JY Gong, OB Goodman, L Cartegni, DM Nanus, R Shen
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2007
Stage-specific Modulation of Neprilysin and Aminopeptidase N in the Limbic System During Kindling Progression
P de Gortari, MA Vargas, A Martínez, AI García-Vázquez, RM Uribe, L Chávez-Gutiérrez, V Magdaleno, G Boileau, JL Charlí, P Joseph-Bravo
Journal of Molecular Neuroscience 2007
Nonreceptor tyrosine kinases in prostate cancer.
Chang YM, Kung HJ, Evans CP
Neoplasia (New York, N.Y.) 2007
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
CA Rothermund, VK Gopalakrishnan, JD Eudy, JK Vishwanatha
BMC urology 2005
Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile
Liu AY, Roudier MP, True LD
The American Journal of Pathology 2004
Protein kinase Cdelta is required for amplify ceramide formation via mitochondrial signaling in prostate cancer cells
Makoto Sumitomo, Motoi Ohba, Junichi Asakuma, Takako Asano, Toshio Kuroki, Tomohiko Asano, Masamichi Hayakawa
Journal of Clinical Investigation 2002
Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma
T Bogenrieder, M Herlyn
Critical Reviews in Oncology/Hematology 2002

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
39 readers on Mendeley
See more details